IOL Chemicals & Pharmaceuticals Ltd Financials
Company Logo

IOL Chemicals & Pharmaceuticals Ltd Financial Statement

IOL Chemicals & Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue532.18
Operating Expense484.19
Net Profit19.15
Net Profit Margin3.60
Earning Per Share3.26
EBIDTA45.77
Effective Tax Rate9.52

IOL Chemicals & Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual2,132.79
Operating Expenses Annual1,901.27
Operating Profit Annual261.59
Interest Annual16.10
Depreciation62.85
Net Profit Annual135.42
Tax Annual47.22

IOL Chemicals & Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.96
Cash Flow from Operations290.76
Cash Flow from Investing-191.69
Cash Flow from Financing-92.50
Cash Flow at the End7.53

IOL Chemicals & Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)12.27
PBIT Margin (%)9.32
PBT Margin (%)8.74
Net PROFIT Margin (%)6.35
Return On Networth / Equity (%)8.69
Return On Networth /Employed (%)12.27
Return On Assets (%)8.38
Total Debt / Equity (X)0.04
Asset Turnover Ratio (%)1.32

IOL Chemicals & Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual933.73
Total Current Assets Annual1,119.48
Non Current Assets Annual1,124.49
Total Shareholders Funds Annual1,611.33
Total Assets Annual2,243.97

IOL Chemicals & Pharmaceuticals Ltd Earning Calls

EPS (INR)

Expected

3.26

Reported

3.26

Surprise

0.00%

Jun 2024

EPS beaten by 0.00%

Mar 2024

EPS beaten by 0.20%

Dec 2023

EPS beaten by 0.21%

Get Your FAQs Right

As of Dec 4, 2024, IOL Chemicals & Pharmaceuticals Ltd has a market capitalization of 2,122.20 Cr. Value Research classifies it as a Mid-Cap company.
Yes, IOL Chemicals & Pharmaceuticals Ltd is debt-free with a debt-to-equity ratio of 0.02.
In FY 2023 , IOL Chemicals & Pharmaceuticals Ltd recorded a total revenue of approximately 2,132.79 Cr marking a significant milestone in the company's financial performance.
IOL Chemicals & Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.0% and -0.0% annually, respectively..
IOL Chemicals & Pharmaceuticals Ltd's current PE ratio is 15.67.
IOL Chemicals & Pharmaceuticals Ltd's ROCE averaged 13.7% from the FY ending March 2022 to 2024, with a median of 13.0%. It peaked at 16.1% in March 2022, reflecting strong capital efficiency over the period..
IOL Chemicals & Pharmaceuticals Ltd's latest EBIT is Rs. 198.74 Cr, surpassing the average EBIT of Rs. 211.94 Cr over the 5 years..
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions